The UK government has conveyed its seriousness about reversing the evident decline in commercial clinical trial activity in the country by promising “decisive action” on all 27 recommendations from an independent review on this topic.
UK Aims To Quadruple Patient Recruitment To Industry Clinical Trials By 2027
The UK government has set aside dedicated funds to deliver ambitious changes that would make it quicker and easier for companies to trial more of their products in the National Health Service.
